Result of AGM

AstraZeneca PLC
28 April 2005


FOR IMMEDIATE RELEASE:

                                ASTRAZENECA PLC

                     ANNUAL GENERAL MEETING : 28 APRIL 2005


AstraZeneca PLC announced the results of the voting at its Annual General
Meeting today.  As proposed in the Notice of AGM, all Resolutions were decided
by poll vote.

Resolution 1:  Ordinary Resolution to receive the Company's Accounts and the
               Reports of the Directors and Auditor for the year ended 
               31 December 2004:

VOTES FOR:            873,031,244 (99.51%)

VOTES AGAINST:          4,257,688  (0.49%)

The Resolution was passed as an Ordinary Resolution.


Resolution 2:  Ordinary Resolution to confirm dividends:

VOTES FOR:            937,709,945 (99.99%)

VOTES AGAINST:             74,287  (0.01%)

The Resolution was passed as an Ordinary Resolution.

Resolution 3:  Ordinary Resolution to re-appoint KPMG Audit Plc, London as
               Auditor:

VOTES FOR:            926,972,277 (99.60%)

VOTES AGAINST:          3,696,073  (0.40%)

The Resolution was passed as an Ordinary Resolution.



Resolution 4:  Ordinary Resolution to authorise the Directors to agree the
               remuneration of the Auditor:

VOTES FOR:            936,624,068 (99.85%)

VOTES AGAINST:          1,406,275  (0.15%)

The Resolution was passed as an Ordinary Resolution.


Resolution 5(a): Ordinary Resolution to re-elect Louis Schweitzer as a Director:

VOTES FOR:            924,631,833 (99.31%)

VOTES AGAINST:          6,423,939  (0.69%)

The Resolution was passed as an Ordinary Resolution.

Resolution 5(b): Ordinary Resolution to re-elect Hakan Mogren as a Director:

VOTES FOR:            899,672,968 (98.23%)

VOTES AGAINST:         16,216,453  (1.77%)

The Resolution was passed as an Ordinary Resolution.

Resolution 5(c): Ordinary Resolution to re-elect Sir Tom McKillop as a Director:

VOTES FOR:            929,646,493 (99.27%)

VOTES AGAINST:          6,827,088  (0.73%)

The Resolution was passed as an Ordinary Resolution.


Resolution 5(d): Ordinary Resolution to re-elect Jonathan Symonds as a Director:

VOTES FOR:            931,173,277 (99.43%)

VOTES AGAINST:          5,334,090  (0.57%)

The Resolution was passed as an Ordinary Resolution.

Resolution 5(e): Ordinary Resolution to elect John Patterson as a Director:

VOTES FOR:            931,197,427 (99.43%)

VOTES AGAINST:          5,296,636  (0.57%)

The Resolution was passed as an Ordinary Resolution.

Resolution 5(f): Ordinary Resolution to elect David R Brennan as a Director:

VOTES FOR:            931,020,554 (99.44%)

VOTES AGAINST:          5,217,080  (0.56%)

The Resolution was passed as an Ordinary Resolution.

Resolution 5(g): Ordinary Resolution to re-elect Sir Peter Bonfield as a
                 Director:

VOTES FOR:            916,239,994 (99.33%)

VOTES AGAINST:          6,152,000  (0.67%)

The Resolution was passed as an Ordinary Resolution.

Item 5(h): Ordinary Resolution to re-elect John Buchanan as a Director:

VOTES FOR:            934,419,882 (99.81%)

VOTES AGAINST:          1,751,260  (0.19%)

The Resolution was passed as an Ordinary Resolution.

Resolution 5(i): Ordinary Resolution to re-elect Jane Henney as a Director:

VOTES FOR:            934,840,524 (99.82%)

VOTES AGAINST:          1,673,320  (0.18%)

The Resolution was passed as an Ordinary Resolution.

Resolution 5(j): Ordinary Resolution to re-elect Michele Hooper as a Director:

VOTES FOR:            934,831,960 (99.82%)

VOTES AGAINST:          1,681,189  (0.18%)

The Resolution was passed as an Ordinary Resolution.

Resolution 5(k): Ordinary Resolution to re-elect Joe Jimenez as a Director:

VOTES FOR:            927,440,873 (99.81%)

VOTES AGAINST:          1,804,049  (0.19%)

The Resolution was passed as an Ordinary Resolution.

Resolution 5(l): Ordinary Resolution to re-elect Erna Moller as a Director:

VOTES FOR:            917,440,168 (99.47%)

VOTES AGAINST:          4,884,711  (0.53%)

The Resolution was passed as an Ordinary Resolution.

Resolution 5(m): Ordinary Resolution to re-elect Dame Bridget Ogilvie as a
                 Director:

VOTES FOR:            934,660,569 (99.80%)

VOTES AGAINST:          1,840,452  (0.20%)

The Resolution was passed as an Ordinary Resolution.

Resolution 5(n): Ordinary Resolution to re-elect Marcus Wallenberg as a
                 Director:

VOTES FOR:            731,241,309 (80.74%)

VOTES AGAINST:        174,378,097  (19.26%)

The Resolution was passed as an Ordinary Resolution.

Resolution 6:  Ordinary Resolution to approve the Directors' Remuneration Report
for the year ended 31 December 2004:

VOTES FOR:            873,578,574 (93.64%)

VOTES AGAINST:          59,346,291 (6.36%)

The Resolution was passed as an Ordinary Resolution.

Resolution 7:  Ordinary Resolution to approve the AstraZeneca Performance Share
Plan:

VOTES FOR:            879,318,037 (96.14%)

VOTES AGAINST:         35,312,192  (3.86%)

The Resolution was passed as an Ordinary Resolution.

Resolution 8:  Ordinary Resolution to authorise limited EU political donations:

VOTES FOR:            918,271,672 (98.53%)

VOTES AGAINST:         13,724,698  (1.47%)

The Resolution was passed as an Ordinary Resolution.

Resolution 9:  Ordinary Resolution to authorise the Directors to allot unissued
               shares:

VOTES FOR:            918,895,155 (98.23%)

VOTES AGAINST:         16,533,339  (1.77%)

The Resolution was passed as an Ordinary Resolution.

Resolution 10:  Special Resolution to authorise the Directors to disapply
                pre-emption rights:

VOTES FOR:            931,126,544 (99.24%)

VOTES AGAINST:          7,165,828  (0.76%)

The Resolution was passed as a Special Resolution.

Resolution 11: Special Resolution to authorise the Company to purchase its own
               shares:

VOTES FOR:            934,858,897 (99.94%)

VOTES AGAINST:            559,704  (0.06%)

The Resolution was passed as a Special Resolution.


G H R Musker
Company Secretary
28 April 2005


                      This information is provided by RNS
            The company news service from the London Stock Exchange